Renalytix PLC (RNLX)
0.6105
-0.01
(-1.05%)
USD |
NASDAQ |
May 13, 14:08
Renalytix Profit Margin (Quarterly): -1.29K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.29K% |
September 30, 2023 | -2.21K% |
June 30, 2023 | -2.14K% |
March 31, 2023 | -1.67K% |
December 31, 2022 | -876.2% |
September 30, 2022 | -1.23K% |
June 30, 2022 | -620.1% |
Date | Value |
---|---|
March 31, 2022 | -1.81K% |
December 31, 2021 | -1.81K% |
September 30, 2021 | -2.10K% |
June 30, 2021 | -1.29K% |
March 31, 2021 | -1.42K% |
December 31, 2020 | -2.23K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.23K%
Minimum
Dec 2020
-620.1%
Maximum
Jun 2022
-1.59K%
Average
-1.67K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
TC BioPharm (Holdings) PLC | -- |
Ainos Inc | -29.77K% |
Biodexa Pharmaceuticals Plc | -- |
Aptorum Group Ltd | -- |
Adaptimmune Therapeutics PLC | -20.74K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -604.9% |
Return on Assets | -149.1% |
Return on Invested Capital | -238.0% |
Gross Profit Margin (Quarterly) | 36.25% |
Operating Margin (Quarterly) | -1.27K% |
Return on Net Operating Assets | -362.4% |